 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | TBNET e.V. |
| Street 1: | Armenberg 6 |
| Street 2: | |
| City: | Bad Oldesloe |
| Province: | Schleswig-Holstein |
| Post Code: | 23845 |
| Country: | Germany |
| Phone: | +**************** |
| Email: | cgerlach@fz-borstel.de |
| Web Site: | http://www.tb-net.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| TBNET is a network of mostly European, research oriented clinicians, microbiologists, mycobacteriologists and epidemiologists interested in the field of tuberculosis and mycobacterial diseases. It was founded in 2006 by a self-organised group of pulmunologists, epedemiologists and specialists in infectous dieseases in Copenhagen. The goal of the TBNET is to promote clinically oriented research in the field of tuberculosis in Europe by sharing and developing ideas and research protocols among the members of the network. These goals have been approached by the conduction of observational cohort studies. In the future, a clinical database will be established and cohort studies as well as prospective clinical trials will be performed. |
|
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 100 + |
| What is your organization's annual budget (USD) dedicated to TB? | < $1,000 |
| How did you hear about the Stop TB Partnership: | Other partners |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| The goal of the TBNET is to promote clinically oriented research in the field of tuberculosis in Europe by sharing and developing ideas and research protocols among the members of the network. These goals have been approached by the conduction of observational cohort studies. In the future, a clinical database will be established and cohort studies as well as prospective clinical trials will be performed. | |
Geographical Reach | |
| Which country is your headquarters located in: | Germany |
| Which WHO region is the main focus of your work: | European |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Argentina Australia Austria Azerbaijan Belarus Belgium Brazil Bulgaria Cameroon Canada Colombia Congo Czech Republic Denmark Egypt Estonia Ethiopia Finland France Germany Ghana Greece India Ireland Israel Italy Japan Latvia Lithuania Luxembourg Malawi Namibia Nepal Netherlands Norway Portugal Republic of Moldova Republic of Serbia Romania Russian Federation Slovakia Slovenia South Africa Spain Sweden Switzerland Tunisia United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Venezuela |
Specializations | |
|
Research and Development |
Specializations in Countries | |
| Research and Development | Argentina |
| Research and Development | Australia |
| Research and Development | Austria |
| Research and Development | Azerbaijan |
| Research and Development | Belarus |
| Research and Development | Belgium |
| Research and Development | Brazil |
| Research and Development | Bulgaria |
| Research and Development | Cameroon |
| Research and Development | Canada |
| Research and Development | Colombia |
| Research and Development | Congo |
| Research and Development | Croatia |
| Research and Development | Czech Republic |
| Research and Development | Denmark |
| Research and Development | Egypt |
| Research and Development | Estonia |
| Research and Development | Ethiopia |
| Research and Development | Finland |
| Research and Development | France |
| Research and Development | Germany |
| Research and Development | Ghana |
| Research and Development | Greece |
| Research and Development | Hungary |
| Research and Development | India |
| Research and Development | Ireland |
| Research and Development | Israel |
| Research and Development | Italy |
| Research and Development | Japan |
| Research and Development | Latvia |
| Research and Development | Lithuania |
| Research and Development | Luxembourg |
| Research and Development | Malawi |
| Research and Development | Namibia |
| Research and Development | Nepal |
| Research and Development | Netherlands |
| Research and Development | Norway |
| Research and Development | Portugal |
| Research and Development | Republic of Moldova |
| Research and Development | Republic of Serbia |
| Research and Development | Romania |
| Research and Development | Russian Federation |
| Research and Development | Slovakia |
| Research and Development | Slovenia |
| Research and Development | South Africa |
| Research and Development | Spain |
| Research and Development | Sweden |
| Research and Development | Switzerland |
| Research and Development | Tunisia |
| Research and Development | Turkey |
| Research and Development | Ukraine |
| Research and Development | United Kingdom of Great Britain and Northern Ireland |
| Research and Development | United Republic of Tanzania |
| Research and Development | United States of America |
| Research and Development | Venezuela |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Drug-Resistant TB: Within the TB-PANNET TBNET operates a large prospective M/XDR TB multicenter database including patient information from 22 European Centers. For further information: http://www.tbpannet.org/ TB-HIV: TBNET is currently preparing a consensus statement for the management of HIV and M. tuberculosis coinfection. previous consensus statements (LTBI, the risk of tuberculosis related to TNF antagonists therapy, the risk of tuberculosis related to transplantation can be found on the TBNET website New Diagnostics: TBNET is developing and evaluating novel diagnostics methods for the identification of individuals at risk for the development of tuberculosis and for the diagnosis of AFB- smear negative tuberculosis. Ongoing projects and publications related to new diagnostics of tuberculosis can be found on the TBNET website. New TB Drugs: TBNET has established clinical trial sites for the evaluation of new anti tuberculosis drugs across Europe and is in contact with industry partners for the evaluation of new drugs. Fundamental Research: Fundamental research projects are being performed at specific TBNET colaborating sites e.g. on topics of immunopathogenics tuberculosis. Operational Research: Three large diagnostics studies involving several thousand individuals from multiple European centers are currently under way to investigate the predictive value of IGRAs for the development of tuberculosis. The TBNET-MDR TB database will allow operational research on questions related to risks therapies and outcomes in drug resistance tuberculosis. |
|
Declaration | |
| Declaration of interests: No conflict of interest is declared | |
| Application date: | March 15, 2012 |
| Last updated: | May 10, 2012 |